Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Purchased by Crestline Management LP
Crestline Management LP lifted its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 74.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,887 shares of the biopharmaceutical company’s stock after acquiring an additional 14,887 shares during the quarter. Crestline […]
More Stories
Amplitude, Inc. (NASDAQ:AMPL) Given Consensus Recommendation of “Reduce” by Analysts
Shares of Amplitude, Inc. (NASDAQ:AMPL – Get Free Report) have earned an average recommendation of “Reduce” from the seven research...
Reviewing Riskified (NYSE:RSKD) and DoorDash (NASDAQ:DASH)
Riskified (NYSE:RSKD – Get Free Report) and DoorDash (NASDAQ:DASH – Get Free Report) are both computer and technology companies, but...
Ennis, Inc. (EBF) To Go Ex-Dividend on October 11th
Ennis, Inc. (NYSE:EBF – Get Free Report) announced a quarterly dividend on Sunday, June 23rd, Wall Street Journal reports. Shareholders...
Direct Line Insurance Group plc (LON:DLG) Given Consensus Rating of “Hold” by Brokerages
Shares of Direct Line Insurance Group plc (LON:DLG – Get Free Report) have been assigned an average rating of “Hold”...
Xcel Energy Inc. (NASDAQ:XEL) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Xcel Energy Inc. (NASDAQ:XEL – Get Free Report) have been given an average rating of “Moderate Buy” by...
Palmer Square Capital BDC Inc. (NYSE:PSBD) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Palmer Square Capital BDC Inc. (NYSE:PSBD – Get Free Report) have been assigned an average rating of “Moderate...